SMTL ID : 4bcg.1

Structure of CDK9 in complex with cyclin T and a 2-amino-4-heteroaryl- pyrimidine inhibitor

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 3.09 Å

Oligo State

hetero-1-1-mer

Ligands

1 x T3C: 2-[[3-(1,4-diazepan-1-yl)phenyl]amino]-4-[4-methyl-2-(methylamino)-1,3-thiazol-5-yl]pyrimidine-5-carbonitrile(Non-covalent)

T3C.1: 14 residues within 4Å: Chain A: I.26, T.30, V.34, A.47, V.80, F.104, D.105, F.106, C.107, E.108, D.110, N.155, L.157, D.168 11 PLIP interactions: 11 interactions with chain A Hydrophobic interactions: A:I.26, A:V.34, A:A.47, A:F.104, A:D.110, A:L.157 Hydrogen bonds: A:T.30, A:T.30, A:C.107, A:C.107, A:D.168

2 x GOL: GLYCEROL(Non-functional Binders)

GOL.2: 6 residues within 4Å: Chain A: I.62, R.66, K.69 Chain B: K.94, V.95, G.97 1 PLIP interactions: 1 interactions with chain A Hydrogen bonds: A:K.69 GOL.3: 5 residues within 4Å: Chain B: Y.38, F.76, P.80, G.81, N.82 3 PLIP interactions: 3 interactions with chain B Hydrogen bonds: B:G.81, B:N.82, B:N.82

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Shao, H. et al., Substituted 4-(Thiazol-5-Yl)-2-(Phenylamino)Pyrimidines are Highly Active Cdk9 Inhibitors: Synthesis, X-Ray Crystal Structure, Sar and Anti-Cancer Activities. J.Med.Chem. (2013)

Release Date

2013-04-17

Peptides

CYCLIN-DEPENDENT KINASE 9: A
CYCLIN-T1: B

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

CYCLIN-DEPENDENT KINASE 9

CYCLIN-T1

Related Entries With Identical Sequence